This content is machine translated Diabetes Cases Management of intolerance to various antidiabetic drugs. A 55-year-old patient, who has had type 2 diabetes mellitus for 15 years, has adverse reactions to a wide variety of antidiabetic drugs that require a change in treatment. In…
View Post 1 min This content is machine translated Diabetes Cases Webcast “Practical Questions on the Current SGED Recommendations 2020” with Prof. Roger Lehmann, M.D. In the webcast, Prof. Lehmann presents the Swiss guidelines for the treatment of type 2 diabetes mellitus , the “most modern and simplest recommendations in the world.” Based on current clinical data,…
View Post 3 min This content is machine translated "A New Era in Diabetes Care" New project to improve diabetes care The recently published expert panel report outlines strategies to optimize treatment for individuals with type 2 diabetes mellitus. Special attention is given to the issue of cardiovascular and renal sequelae.
View Post 5 min This content is machine translated COVID-19 and rheumatism Do not discontinue immunosuppressants! The SARS-CoV-2 pandemic poses special challenges for physicians and patients – even more so if the latter have pre-existing conditions and are on immunosuppressive drugs. Researchers have explored the question…
View Post 5 min This content is machine translated PUBLICITY/ADVERTISEMENT Semaglutide – a GLP-1 analogue from a cardiovascular perspective. GLP-1 analogs are modeled on the natural GLP-1 (glucagon-like peptide 1). In studies, they show potent HbA1C control and weight reduction in patients with type 2 diabetes.1,2,* Their positive effect…
View Post 4 min This content is machine translated Diabetes Cases Cardio-renal protection as an important goal in type 2 diabetes. Cardio-renal protection is one of the most important goals in the management of type 2 diabetes mellitus. Therefore, SGED/SSED recommendations for the treatment of type 2 diabetes mellitus include a…
View Post 4 min This content is machine translated Type 2 diabetes Recommendations for the choice of therapy up to date In recent years, the treatment of type 2 diabetes has been expanded to include more and more options. However, this adds to the complexity of therapy selection. So what can…
View Post 4 min This content is machine translated Sponsored Content Semaglutide – a modern GLP-1 analogue in type 2 diabetes People with type 2 diabetes have too little endogenous GLP-1 (glucagon-like peptide 1). Semaglutide, which mimics natural GLP-1, can compensate.1 Like endogenous GLP-1, it normalizes blood glucose, supports weight loss,…
View Post 2 min This content is machine translated Diabetes Cases Diabetes treatment for increased risk to heart and kidney How should a typical diabetic patient, 55-year-old, obese, with hypertension, dyslipidemia, and reduced renal function be treated?
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 2 min This content is machine translated Biologics for psoriasis Head-to-head study delivers exciting results Interleukin-23 and interleukin-17A play an important role in the inflammatory process of plaque psoriasis. A comparison of two agents directed against these targets in moderate to severe plaque psoriasis led…
